Essential Drugs Monitor No. 025-026 (1998)
(1998; 36 pages) [French] [Russian] [Spanish] View the PDF document
Table of Contents
Open this folder and view contentsEditorial. Managing Drug Supply
Open this folder and view contentsNational Drug Policy
Open this folder and view contentsResearch
Open this folder and view contentsTraining
Close this folderNewsdesk
View the documentAddressing supply issues in the Eastern Caribbean
View the documentChange at WHO
View the documentRational use conference in Palestine
View the documentExecutive Board acts on Revised Drug Strategy
View the documentAfrican countries share information on drug prices
View the documentFirst national formulary for Australia
View the documentUK study says patients not receiving information they need
View the documentControlling research data and updating for the Internet: journal editors revise guidelines
View the documentIDA celebrates and looks to the future
View the documentPrimary health care systems for the 21st Century - the need for vision and values
View the documentIncreased local production of essential drugs on agenda in Africa
View the documentBrazil’s doctors turn on to evidence-based medicine
View the documentGoodbye AHRTAG, welcome Healthlink Worldwide
View the documentDrugs sold on Internet: WHA acts
Open this folder and view contentsDrug Information
View the documentMeetings & Courses
View the documentNetscan
View the documentLetters to the Editor
View the documentPublished Lately
Open this folder and view contentsRational Use
 

African countries share information on drug prices

ALTHOUGH the availability of essential drugs in Africa has improved during the last decade, it is estimated that one-third to a half of the 700 million people in the region still do not have regular access to the drugs they need. Over 40% of deaths in Africa are due to infectious diseases for which effective medicines exist, but which are not available to those who are ill.

Drug shortages remain chronic in most African countries due to such factors as inadequate national supply systems and weak implementation of national drug policies. Poor knowledge of the international drug market and the lack of effective national quality assurance systems can lead to excessive prices and low quality products. Appropriate and objective information on drug prices and quality standards is therefore essential for drug procurement agencies.

In order to help countries in the region to address these issues, WHO’s Regional Office for Africa, in collaboration with the Action Programme on Essential Drugs, has developed the AFRO Intensified Essential Drugs Programme. The new programme will focus on capacity building, strengthened drug supply systems, including quality assurance, and the rational use of drugs.

One priority activity is the AFRO Essential Drugs Price Indicator. This new publication shares information on current drug procurement prices in Africa with the aim of providing purchasing bodies with a better negotiating position. Data in the first edition are based on the latest regular tender information received from public drug procurement agencies, such as central medical stores, in 16 African countries. The information covers drug designation, package size, unit, price, supplier, currency used and exchange rate in US$. A comparison of prices from international suppliers, compiled by Management Sciences for Health, is also included to provide a global perspective.

Copies of the AFRO Essential Drugs Price Indicator are available, free of charge, from: Essential Drugs Programme, WHO Regional Office for Africa, P.O. Box BE 773, Belvedere, Harare, Zimbabwe, or from Action Programme on Essential Drugs, World Health Organization, 1211 Geneva 27, Switzerland.

ESSENTIAL DRUGS

MONITOR


The Essential Drugs Monitor encourages the reproduction of articles for non profit uses.

Please clearly credit WHO’s Essential Drugs Monitor as the source, and send us a copy of the reprinted article to the address given on page 1.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018